Case report; meta-synchronous triple malignancy in primary diagnosed CML patient

Area of Science:

• Oncology
• Hematology
• Hepatology

Background:

• Multiple primary malignancies in a single patient are uncommon, presenting diagnostic and therapeutic challenges.
• Synchronous or metachronous diagnoses of different cancer types have been reported sporadically.
• Understanding the interplay between distinct cancers is crucial for advancing patient care.

Observation:

• A male patient initially diagnosed with chronic myeloid leukemia (CML).
• Subsequently, the patient developed T-lymphoblastic lymphoma.
• Later, hepatocellular carcinoma (HCC) was discovered as a third distinct malignancy.

Findings:

• The co-occurrence of CML, T-lymphoblastic lymphoma, and HCC in one patient is exceptionally rare.
• These malignancies originate from different cell lineages with distinct biological and cytogenetic profiles.
• The absence of typical risk factors like radiation, chemotherapy, or transplantation further underscores the rarity.

Implications:

• This case challenges current understanding of multi-cancer development.
• It emphasizes the need for vigilant surveillance in patients with initial malignancies.
• Further research into the potential underlying mechanisms driving such rare occurrences is warranted.